cl post solid organ sale growth acceler
yoy/two-year averag basi coupl gm upsid still
prefer ow rate pg hpc higher growth potenti
visibl mind sustain turnaround
strong breadth improv similar valuat
high qualiti in-lin ep organ sale rebound cl stock
post ep strong expect
organ sale growth well gross margin upsid view quarter
result posit note top-line result start inflect cl two-
yr average organ sale growth well
organ sale upsid driven primarili emerg
market hill busi sign cl strategi chang gain
traction result also high qualiti bp gm upsid
bp y-o-i yoy expans cl expect continu unquantifi gm
expans reinvest ad spend yoy
bp sale net result impress see low-msd
ep growth guidanc reason greater confid
colgat strategi chang bear fruit howev look
evid sustain strong organ sale growth even posit surpris
quarter improv colgat market share trend stronger
breadth improv across colgat portfolio also note colgat
price-to-earnings premium pg prefer household product name
believ offer higher growth potenti better visibl
gross margin upsid continu market share loss cl gross margin
consensu expect bp increas bp y-o-i
driven cl funding-the-growth save bp higher price
bp favor mix primarili filorga bp partial off-set
unfavor raw materi costs/fx bp cl guid gross margin
expans driven underli busi mix benefit
filorga acquisit well posit price product off-set
modest raw materi inflat colgat oral care market share full year
global toothpast global manual toothbrush
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
respect us toothpast us manual toothbrush
respect quarter market share declin bp y-o-i global
toothpast share bp global toothbrush well bp
respect us toothpaste/toothbrush although highlight given
round number could exagger
detail call colgat sound pleas success behind core
brand relaunch includ colgat total scienc diet relaunch
hill busi contribut strong growth cl overal sound
confid sustain hill growth total organ sale growth
point hill north america busi deliv dd growth
also cycl dd comparison colgat commentari emerg
market mostli posit categori emerg market grow
twice rate develop market latin america busi solid
specif mexico brazil categori grow macro
improv brazil although manag note uncertainti mexico due
recess africa volatil year ago manag feel
comfort consist growth south africa one cl
largest market deliv good growth commentari around asia
mix despit strong organ growth comp easi
turnaround expect take time cl eye
sustain long-term turnaround china specif cl plan enter
strateg relationship expand e-commerc busi possibl
alibaba jd colgat e-commerc busi also consider strong
total e-commerc y-o-i hill cl
expect hello oral strong e-commerc busi contribut
growth go cl three top prioriti premium innov
drive growth mostli expand opportun like whiten
natur product lifestyl hello oral acquisit exampl
becom digit data driven drive effici
deliv product across busi simplifi suppli chain
number cl ep in-lin consensu
estim high qualiti gross profit upsid off-set higher
expect expens cl organ sale growth unround
strong volum well price street account
consensu two-year averag organ sale growth
acceler vs organ sale
growth driven emerg market y-o-i in-lin
organ sale upsid
driven latin america asia pet report sale beat better
expect organ sale growth augment better expect
gross margin gm bp consensu bp y-o-i translat
gross profit beat howev higher expect sg
consensu higher expens cent ep impact vs model drove
oper profit miss bp model sale
bp y-o-i sale oper profit line lower interest
expens cent tailwind vs model yoy
yoy
organ sale growth divis latin america asia africa/eurasia pet
drove upsid quarter north america organ sale grew y-o-i
consensu mse latin america
consensu mse volum gain led mexico colombia europ
vs consensu mse volum gain
franc nordic region partial off-set volum declin
germani unit kingdom asia pacif vs consensu
mse volum gain led greater china region
philippin africa/eurasia vs consensu mse
behind volum gain russia south africa pet organ sale growth
consensu mse volum gain us
western europ partial off-set volum declin japan south africa
develop market organ sale grew y-o-i y-o-i growth
initi ep guidanc visibl look reason cl issu initi
ep guidanc l-msd increas impli ep rang
midpoint base vs prior consensu mse
impli slight neg revis ad spend reinvest
robust expect y-o-i organ sale growth view guidanc
visibl solid margin level cl expect gross margin expans
higher advertis cl guidanc includ recent announc hello
acquisit expect flat penni dilut ep
report sale growth includ benefit acquisit
filorga hello well modest neg impact fx
ew net post ep ep unchang increas vs
ep move one penni pt move
base ep reflect higher top-line outlook
base case scenario
organ top-line drive multipl expans bp volum upsid
share gain bp price upsid drive multipl expans
bull case ep includ strateg halo
top-line growth rang forecast lt top-line growth
limit cl market share struggl appli price-to-earnings multipl
multipl appli pg given lower top-line growth cl lower
sale growth deceler flattish rang secular us pressur drive bp
price downsid bp volum loss bp reinvest
spur top-line weak macro difficult competit environ drive
bp volum bp price invest intern appli
exhibit bear bull top-line upside/downsid driver cl multipl
valu
top-line growth toward low-end
growth remain rang lt post
cl msd histor
trend lower half cl lt
target believ cl organ sale growth
emerg market return
histor level due heighten
competit local player competit
environ compani shift spend
secularli challeng us market
well lower inflationari price compar
last year
diminish strateg still
believ cl advantag vs peer
greater mix higher growth emerg
market person care product
categori believ market
attribut lower strateg halo
histor given weaker fundament
compar histor trend note
knowledg potenti transact
colgat line valuat mega-cap
peer compel consid subdu
top-line growth outlook cl
risk achiev price
market share payback ad spend
cost consolid potenti increas
downsid risk weaker price
market share loss local player
higher commod cost strateg
sale
sale
sale bp chang
sale
sale bp chang
sale
sale bp chang
note loan payabl
current portion long-term debt
pt forecast organ top-line growth hsd ep growth
beyond appli price-to-earnings multipl base case ep cpg
peer driven strong price power ko transform higher growth/roic
concentr model bottl divestitur posit chang new
volatil health well pressur lower expect product soda
pt forecast organ sale growth go forward hpc
peer led improv us result build market share momentum better price
realiz continu cost save support bp om expansion/yr drive
hsd ep growth appli multipl ep slight premium pg
share vacil currenc commod volatil
pt organ sale growth beyond driven solid
snack growth om expand bp annual post reinvest cost
save assum price-to-earnings slightli lt histori reflect higher top-line
growth potenti forward risk vs consensu
upsid risk re-acceler flna snack top-line growth improv
north america beverag busi higher invest spend better gross
margin expans favor commod and/or better price realiz higher
expect cost save restructur
downsid risk lower expect return reinvest
russia/mexico/china macro volatil commod cost fx volatil
acceler competit intens beverag soda tax health-rel
